Latest stories on FATE
S&P 500, Nasdaq, Dow End Higher Led By Chipmaker Stocks As Investors Look Past US-Iran Hostility — ORCL, SBUX, WULF, PANW, FATE In Focus
Stocktwits News58 · neutralgeneral
FATE Stock Jumps 6% As FDA Greenlights Moving Cell Therapy To Clinical Trials
Stocktwits News67 · bullishproduct/pr
Fate Therapeutics Receives FDA Clearance of Investigational New Drug Application for FT839 Product Candidate | FATE Stock News
StockTitan67 · bullishproduct/pr
Fate Therapeutics: There Is A Bull Case, But It's Going To Take Time To Develop (Rating Downgrade)
Seeking Alpha56 · neutralproduct/pr
Fate Therapeutics to Participate in Upcoming Third Quarter 2026 Conferences | FATE Stock News
StockTitan55 · neutralgeneral
Fate Therapeutics: FT819 Progress Keeps My Bull Case Alive
Seeking Alpha63 · neutralproduct/pr
FATE THERAPEUTICS INC (FATE) files 8-K
SEC 8-K50 · neutralgeneral
Fate Therapeutics Appoints Laura Hamill to Board of Directors | FATE Stock News
StockTitan55 · neutralgeneral
Fate Therapeutics Advances Off-the-Shelf CAR-T Autoimmune Pipeline
TipRanks63 · neutralproduct/pr
Fate Therapeutics Reports New Employee Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) | FATE Stock News
StockTitan50 · neutralgeneral
Fate Therapeutics Showcases Clinical Data for FT836 at the American Society of Cancer Oncology Annual Meeting | FATE Stock News
StockTitan63 · neutralproduct/pr
[144] FATE THERAPEUTICS INC SEC Filing
StockTitan SEC50 · neutralgeneral